Treace Medical Concepts Q3 EPS $(0.28) Misses $(0.26) Estimate, Sales $40.76M Miss $42.05M Estimate
Portfolio Pulse from Benzinga Newsdesk
Treace Medical Concepts (NASDAQ:TMCI) reported Q3 losses of $(0.28) per share, missing the analyst consensus estimate of $(0.26) by 7.69%. This is a 27.27% decrease over losses from the same period last year. The company also reported quarterly sales of $40.76 million, missing the analyst consensus estimate of $42.05 million by 3.07%. However, this is a 23.30% increase over sales from the same period last year.
November 09, 2023 | 9:14 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Treace Medical Concepts reported Q3 losses and sales that missed analyst estimates. However, sales increased by 23.30% compared to the same period last year.
Treace Medical Concepts reported Q3 losses and sales that missed analyst estimates, which could negatively impact the stock price in the short term. However, the YoY increase in sales could potentially offset some of this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100